Latest News and Press Releases
Want to stay updated on the latest news?
-
KOMO Biosciences announced that it has granted Syngenta , a Research Evaluation License to assess aspects of KOMO’s proprietary KOMbine™ platform.
Want to stay updated on the latest news?
KOMO Biosciences announced that it has granted Syngenta , a Research Evaluation License to assess aspects of KOMO’s proprietary KOMbine™ platform.